Bright Way Group

Bright Way Group, operating under the brand Velpharm, is a specialized pharmaceutical manufacturing entity based in Moscow, Russia. The company focuses on the development and production of high-quality, affordable medications, aiming to increase the domestic market share of pharmaceutical products to 50% by 2030. By leveraging advanced manufacturing technologies and a robust R&D pipeline, Bright Way Group currently maintains a portfolio of over 12 commercialized medications, with an additional 27 products currently in various stages of development.

The organization operates with a workforce of 500-1,000 employees, supporting complex pharmaceutical operations and supply chain logistics. Meet Bright Way Group's team to understand the technical expertise driving their R&D and manufacturing capabilities. Their operational model integrates contract manufacturing and licensed production services, providing scalable solutions for pharmacy networks and healthcare professionals. This infrastructure allows the firm to maintain high standards of quality control while meeting the evolving demands of the Russian healthcare sector.

With an annual revenue of $37.1M, Bright Way Group continues to expand its footprint within the pharmaceutical industry. The company’s strategic focus remains on enhancing domestic production capacity through technological innovation and professional development initiatives. By prioritizing the integration of modern pharmaceutical manufacturing processes, the firm positions itself as a key player in the regional healthcare market. Their commitment to expanding product offerings and fostering industry partnerships underscores their long-term growth strategy in the competitive pharmaceutical landscape.